Skip to main content
. 2014 Feb;5(1):57–66. doi: 10.3978/j.issn.2078-6891.2013.056

Table 2. Drug-related AEs occurring in ≥5% of patients (and all grade 3/4 AEs).

AEa n [%] Gefitinib related
Celecoxib related
Grade 1/2 Grade 3/4 Grade 1/2 Grade 3/4
Acne 11 [37] 1 [3] 1 [3] 0 [0]
Diarrhea 10 [33] 1 [3] 3 [10] 0 [0]
Stomatitis 4 [13] 0 [0] 4 [13] 0 [0]
Skin desquamation 4 [13] 0 [0] 2 [7] 0 [0]
Nausea 3 [10] 0 [0] 4 [13] 0 [0]
Rash 2 [7] 0 [0] 0 [0] 0 [0]
Pruritus 2 [7] 0 [0] 0 [0] 0 [0]
Abdominal pain 1 [3] 0 [0] 2 [7] 0 [0]
Vomiting 1 [3] 0 [0] 2 [7] 0 [0]
Hypotension 0 [0] 1 [3] 0 [0] 0 [0]
Upper abdominal pain 0 [0] 0 [0] 3 [10] 0 [0]
Hepatitis 0 [0] 0 [0] 0 [0] 1 [3]
Folliculitis 0 [0] 1 [3] 0 [0] 0 [0]

aA patient could have ≥1 AE. AE, adverse event.